Association of aortic valvular complex calcification burden with procedural and long-term clinical outcomes after

Euihong Ko1, Do-Yoon Kang1, Jung-Min Ahn1

  • 1Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.

Insights

Higher valvular/subvalvular calcium burden in transcatheter aortic valve replacement (TAVR) patients correlated with increased paravalvular leakage and pacemaker needs. However, adjusted long-term composite outcomes and mortality risks were not significantly affected by calcium levels.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • Severe aortic stenosis (AS) necessitates intervention, with transcatheter aortic valve replacement (TAVR) being a primary treatment.
  • Valvular and subvalvular calcification are common in AS patients undergoing TAVR.
  • The prognostic impact of baseline calcium burden on TAVR outcomes requires further elucidation.

Purpose of the Study:

  • To evaluate the association between valvular/subvalvular calcium burden and procedural/long-term outcomes following TAVR.
  • To stratify patients based on calcium volume tertiles and assess their clinical trajectories.

Main Methods:

  • Prospective observational cohort study of 676 AS patients undergoing TAVR (March 2010-December 2019).
  • Baseline calcium burden quantified via multidetector computed tomography and categorized into tertiles.
  • Procedural outcomes (paravalvular leakage, permanent pacemaker insertion) and 12-month clinical outcomes (composite of death, stroke, rehospitalization; all-cause mortality) were analyzed.

Main Results:

  • Moderate/severe paravalvular leakage and permanent pacemaker insertion rates increased proportionally with higher calcium tertiles (P-for-trend < 0.05).
  • The 12-month composite outcome rate was significantly different across tertiles (log-rank P = 0.02), but multivariable analysis showed no significant difference in adjusted risks (middle-tertile HR 0.81; high-tertile HR 0.93).
  • All-cause mortality followed a similar pattern, with no significant adjusted differences between calcium groups.

Conclusions:

  • While increased valvular/subvalvular calcium burden is associated with higher rates of procedural complications like paravalvular leakage and permanent pacemaker insertion, it does not appear to significantly impact adjusted 12-month composite outcomes or all-cause mortality after TAVR.
  • Calcium burden assessment may inform procedural risk stratification but does not appear to be an independent predictor of long-term adverse events in this cohort.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
164
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
89
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
79
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
81
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
52
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
47